Table 2.

Revised Karyotypes of the Patients With t(5;11)

Patient No. Age (yr)/ Sex Disease Revised Karyotype
1  3/F  AML-M2  46,XX,del(5)(q2?2q3?3).ish der(5) t(5;11)(q35;p15.5)del(5)(q2?2q35) (wcp5+; cos84C11+, cos113-1+, D5S671−, DRD1−, c13−, c15-2−, HRAS1-HRC+, cos2209a2+; wcp11−),der(11)t(5;11)(q35;p15.5)(wcp5+; cosB22a4+, FLT4+, RDPX1+, cos2072c1+; wcp11+)  
2  3/M  AML-M4 46,XY,del(5)(q13q3?3).ish der(5) t(5;11)(q35;p15.5)del(5)(q13q35) (wcp5+; cos84C11+, cos113-1+, D5S671−, DRD1−, c13−, c15-2−, HRAS1-HRC+, cos2209a2+),der(11) t(5;11)(q35;p15.5)(wcp5+; cosB22a4+, FLT4+, RDPX1+, cos2072c1+)  
3  12/M  AML-M2 46,XY,del(5)(q14q34).ish der(5) t(5;11)(q35;p15.5)del(5)(q14q31) (wcp5+, cos84C11+, cos113-1+, 5q31Oncor−, ADRB2+, SPARC+, GR1A1+, IL12B+, D5S671+, c13+, c15-2+,HRAS1-HRC+, cos2209a2+), der(11)t(5;11)(q35;p15.5)(wcp5+; cosB22a4+, FLT4+, RDPX1+, cos2072c1+) 
Patient No. Age (yr)/ Sex Disease Revised Karyotype
1  3/F  AML-M2  46,XX,del(5)(q2?2q3?3).ish der(5) t(5;11)(q35;p15.5)del(5)(q2?2q35) (wcp5+; cos84C11+, cos113-1+, D5S671−, DRD1−, c13−, c15-2−, HRAS1-HRC+, cos2209a2+; wcp11−),der(11)t(5;11)(q35;p15.5)(wcp5+; cosB22a4+, FLT4+, RDPX1+, cos2072c1+; wcp11+)  
2  3/M  AML-M4 46,XY,del(5)(q13q3?3).ish der(5) t(5;11)(q35;p15.5)del(5)(q13q35) (wcp5+; cos84C11+, cos113-1+, D5S671−, DRD1−, c13−, c15-2−, HRAS1-HRC+, cos2209a2+),der(11) t(5;11)(q35;p15.5)(wcp5+; cosB22a4+, FLT4+, RDPX1+, cos2072c1+)  
3  12/M  AML-M2 46,XY,del(5)(q14q34).ish der(5) t(5;11)(q35;p15.5)del(5)(q14q31) (wcp5+, cos84C11+, cos113-1+, 5q31Oncor−, ADRB2+, SPARC+, GR1A1+, IL12B+, D5S671+, c13+, c15-2+,HRAS1-HRC+, cos2209a2+), der(11)t(5;11)(q35;p15.5)(wcp5+; cosB22a4+, FLT4+, RDPX1+, cos2072c1+) 

FISH nomenclature, ISCN, 1995.39 

or Create an Account

Close Modal
Close Modal